Skip to main content Skip to section navigation Skip to footer

Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

NASDAQ:LEXX; NASDAQ WARRANT:LEXXW

Home
About
Technology
Licensing Opportunities
Investors

Presentations

Investors

Overview
News & Events
Presentations
Company Info
Analyst Coverage
Financial Info
Stock Data
SEC Filings
SEDAR+
Legend Removal
Governance

Nov 2, 2023

Corporate Presentation

Nov 2, 2023

Corporate Highlight Sheet

Email Alerts
Contacts
RSS News Feed

Lexaria Bioscience Corp. (NASDAQ:LEXX) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules.

250.765.6424
info@lexariabioscience.com

Canadian Operations
#100-740 McCurdy Road
Kelowna, BC, V1X2P7

US Operations
2226 W. Northern Avenue
Phoenix, AZ 85021

General Disclaimer:
No statement in this web site has been evaluated by the Food and Drug Administration (FDA). Furthermore, none of the statements in this web site should be construed as dispensing medical advice or making claims regarding the cure of diseases…

Copyright ©2023 All rights reserved.

Back to the top